Status:
UNKNOWN
A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
Lead Sponsor:
NHS Greater Glasgow Yorkhill Division
Conditions:
Epistaxis
Eligibility:
All Genders
1-14 years
Phase:
PHASE4
Brief Summary
To determine whether the selective application of a combined treatment regimen of silver nitrate cautery and 4 weeks of Naseptin cream is superior to naseptin treatment alone in the management of recu...
Eligibility Criteria
Inclusion
- Children aged 1 - 14
- History of repeated epistaxis with at least 1 episode in the previous 4 weeks prior to attending the ENT clinic.
- Presence of prominent vessels on the anterior nasal septum on the side that reportedly bleeds (or on at least one side if bleeding is reported to be bilateral)
Exclusion
- No prominent vessels on examination (these children will be randomised but will be prescribed Naseptin alone and followed up in the same way as the children in the trial, for completeness of data)
- Known bleeding disorders.
- Allergy to peanuts, neomycin or chlorhexidine
- Other causes of nose bleeding eg tumour.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT00390663
Start Date
October 1 2006
Last Update
October 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Hospital for Sick Children
Glasgow, Strathclyde, United Kingdom, G3 8SJ